IRBO

iShares Robotics and Art... (IRBO)

iShares Robotics and Artificial Intelligence Multisector ETF

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:IRBO

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
27/08/2007	21:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells	AMEX:IRBO
23/08/2007	21:00	PR Newswire (US)	ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information	AMEX:IRBO
16/08/2007	21:00	PR Newswire (US)	ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook	AMEX:IRBO
07/08/2007	22:00	PR Newswire (US)	ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.	AMEX:IRBO
23/07/2007	21:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. to Present Homspera(TM) at 2007 BARDA Industry Day	AMEX:IRBO
19/07/2007	21:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. and Virion Systems, Inc. Continue Testing Viprovex(R) and Tamiflu(R) as Possible Influenza Co-Trea	AMEX:IRBO
12/07/2007	23:16	PR Newswire (US)	ULURU Inc. Announces Co-Development Agreement for Potential Advanced Wound Care Therapeutic	AMEX:IRBO
12/07/2007	21:00	PR Newswire (US)	ImmuneRegen BioSciences Announces Development Partnership With Uluru Inc.	AMEX:IRBO
07/05/2007	22:00	PR Newswire (US)	IR BioSciences Announces Promising Data from Study of Its Compound Homspera	AMEX:IRBO
26/04/2007	00:07	PR Newswire (US)	IR BioSciences Appoints Celgene Executive Dr. Robert Hariri to Its Board of Directors	AMEX:IRBO
21/03/2007	00:08	PR Newswire (US)	ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent	AMEX:IRBO
15/03/2007	02:47	PR Newswire (US)	IR BioSciences, Inc. Responds to the Recently Cancelled Acute Radiation Syndrome (ARS) RFP by DHHS	AMEX:IRBO
09/03/2007	02:11	PR Newswire (US)	IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal	AMEX:IRBO
26/02/2007	23:00	PR Newswire (US)	IR BioSciences Holdings, Inc. to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiati	AMEX:IRBO
09/02/2007	10:32	PR Newswire (US)	/C O R R E C T I O N -- ImmuneRegen BioSciences, Inc./	AMEX:IRBO
09/02/2007	00:00	PR Newswire (US)	ImmuneRegen's Viprovex Demonstrates Immune Response Potential in Treatment of Avian Influenza and Spanish Flu	AMEX:IRBO
18/01/2007	23:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Retains Battelle for Radiation and Infectious Disease Testing	AMEX:IRBO
16/01/2007	23:00	PR Newswire (US)	ImmuneRegen Achieves Key Milestone in Testing of Potential Infectious Disease Treatment	AMEX:IRBO
09/01/2007	23:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Demonstrates That Viprovex(TM) Is a Potential Treatment for Avian and Other Influenzas	AMEX:IRBO
04/01/2007	23:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Announces First Study of Viprovex(TM) to Explore Adjuvant Capabilities in the Area of Pandemic Inf	AMEX:IRBO
04/01/2007	23:00	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Announces First Study of Viprovex(TM) to Explore Adjuvant Capabilities in the Area of Pandemic Inf	AMEX:IRBO
03/01/2007	23:00	PR Newswire (US)	ImmuneRegen BioSciences Appoints Hal Siegel, Ph.D. as Senior Director of Product Development & Regulatory Affairs	AMEX:IRBO
03/01/2007	23:00	PR Newswire (US)	ImmuneRegen BioSciences Appoints Hal Siegel, Ph.D. as Senior Director of Product Development & Regulatory Affairs	AMEX:IRBO
11/12/2006	23:00	PR Newswire (US)	ImmuneRegen BioSciences Responds to Department of Health and Human Services Request for Information for Medical Countermeasures	AMEX:IRBO
07/12/2006	23:00	PR Newswire (US)	ImmuneRegen BioSciences Closes Round of Funding	AMEX:IRBO
30/08/2006	22:30	PR Newswire (US)	ImmuneRegen Begins Next Study With Oak Ridge National Laboratory (ORNL)	AMEX:IRBO
17/08/2006	22:00	PR Newswire (US)	ImmuneRegen Announces Further Results From Anthrax Treatment Study	AMEX:IRBO
02/08/2006	22:00	PR Newswire (US)	ImmuneRegen Product to be Tested as Defense to Potential Biological Weapon	AMEX:IRBO
31/07/2006	22:00	PR Newswire (US)	Singapore's DSO National Laboratories to Study ImmuneRegen's Viprovex(TM)	AMEX:IRBO
24/07/2006	22:00	PR Newswire (US)	NIH to Conduct Preclinical Evaluation of ImmuneRegen's Radilex(TM)	AMEX:IRBO